Ischemic Stroke
Classification of Ischemic Stroke
# Etiologies Overall
ASCOD (2013) π
Atherosclerosis
Small-vessel disease
Cardiac pathology
Other cause
Dissection
TOAST (Trial of Org 10172 in Acute Stroke Treatment) (1993) πΊπΈ
Large-artery atherosclerosis
Cardioembolism
Small-artery occlusion (lacune)
Other cause
Stroke of undetermined etiology
Causative Classification of Stroke System (CCS) (2010) π
Supra-aortic large-artery atherosclerosis
Cardioaortic embolism
Small-artery occlusion
Other uncommon causes
Undetermined
# Types of Embolic Strokes
THROMBEX (2021) π©πͺ
Cardioembolic
Arterioembolic
Other
Embolic stroke of undetermined source (ESUS)
Diagnosis of Ischemic Stroke
# Examination
NIH Stroke Scale (NIHSS) (2024) πΊπΈ
NIHSS calculator (MDCalc) πΊπΈ
Canadian TIA score (2021) π¨π¦
Canadian TIA score calculator (MDCalc)
ABCD2 score (2007) π
ABCD2 calculator (MDCalc)
# Imaging
Alberta Stroke Program Early CT Score (ASPECTS) (2000) π¨π¦
ASPECTS discussion (Radiopaedia)
ASPECTS calculator (MDCalc)
MRI imaging of acute stroke: DWI, ADC, T2 phases (2001) πΊπΈ
Management of Ischemic Stroke
# Hyperacute Stroke
Canada Stroke Best Practices (2022) π¨π¦
Time Windows (2022) π¨π¦
IV Thrombolysis Criteria (2022) π¨π¦
EVT Criteria (2022) π¨π¦
Extended EVT window Criteria (2022) π¨π¦
American Stroke Association (2019) πΊπΈ
# Complications of IV Thrombolysis
American Stroke Association (2019) πΊπΈ
# Secondary Stroke Prevention
Canada Stroke Best Practices (2022) π¨π¦
π Medications
# Antiplatelet
Acetylsalicylic acid
Thrombosis Canada π¨π¦
HRES Product Monograph (2021) π¨π¦
Clopidogrel (Plavix)
Thrombosis Canada π¨π¦
HRES Product Monograph (2020) π¨π¦
FDA Product Monograph (2009) πΊπΈ
Ticagrelor (Brilinta)
Thrombosis Canada π¨π¦
HRES Product Monograph (2021) π¨π¦
FDA Product Monograph (2020) πΊπΈ
# Anticoagulation
DOAC Comparison (Thrombosis Canada, 2023) π¨π¦
DOAC Interactions (Thrombosis Canada, 2020) π¨π¦
Apixaban (Eliquis)
Thrombosis Canada π¨π¦
HRES Product Monograph (2019) π¨π¦
FDA Product Monograph (2014) πΊπΈ
Rivaroxaban (Xarelto)
Thrombosis Canada π¨π¦
HRES Product Monograph (2021) π¨π¦
FDA Product Monograph (2021) πΊπΈ
Edoxaban (Lixiana, Savaysa)
Thrombosis Canada π¨π¦
HRES Product Monograph (2021) π¨π¦
FDA Product Monograph (2015) πΊπΈ
Dabigatran (Pradaxa)
Thrombosis Canada π¨π¦
HRES Product Monograph (2019) π¨π¦
FDA Product Monograph (2015) πΊπΈ
Warfarin (Coumadin)
Thrombosis Canada π¨π¦
HRES Product Monograph (2017) π¨π¦
FDA Product Monograph (2017) πΊπΈ
π Landmark Trials
IV Thrombolysis
Retrospective (2015)
Retrospective (2010)
DAPT for high-risk TIA and minor stroke
Editorial (NEJM, 2023)
Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) (2013) π¨π³
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) (2018) π
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke (ARAMIS) (2023) π¨π³
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES) (2023) π¨π³
Anticoagulation for Afib after stroke
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation (ELDERCARE-AF) (2020) π―π΅
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation (ELAN) (2023) π